Search
12/09/2025
A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of developing bronchopulmonary dysplasia
Alonso-Ojembarrena, A, Poindexter, B, Aleem, S, Healy, H, Aguar-Carrascosa, M, Moliner-Calderón, E, Serrano-Martin, MD, Arroyo, R, Vento, M. A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of developing bronchopulmonary dysplasia. Frontiers in Pediatrics. 2025; 13DOI:10.3389/fped.2025.1639573. PMID:41018057. IF:2.000(Q2/4D).
10/09/2025
Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline
Park, HS, del Campo, PD, Plana, MN, La Borda, JPY, Guerra-Rodriguez, M, Moreno, M, Cañete, JD. Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1621313. PMID:41001393. IF:3.000(Q1/2D).
09/09/2025
Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results
Rubio-Briones, J, Borque-Fernando, A, Escaño, LME, Wong, A, Cascales, AG, Gómez, EG, Fabra, JMG, Sanguedolce, F, Gomez-Veiga, F, González, PAL, Bello, AP, Garcia, NR, Semper, MM, Novo, JFS, Hajianfar, R, Ciutat, LLF, Alfaro, AG, Ojeda, JMD, Ariño, AB, Dorado, CQ, Iriarte, AL, Fadrique, GG, Bachs, JMG, Barreras, SG, Costa, YP, Cabo, AV, Aliaga, MR, Perez, FC, Servián, P, Bortoló, JMC, Delgado, MS, de Ledesma, JMR, Rodriguez, CS, Abal, VC, Martinez, YEH, Imbroda, BH, Dolezal, P, Frau, JG, Llorente, PM, Jimenez, JM, Uribe, JSS, Ruiz, CBC, Reyes, A, Aparicio, TF, Rodriguez, JG, Sole, MC, Segui, AG, Bru, JJP, de Castro, JM, Moreno, AM, Suárez, JLM. Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results. Cancer Medicine. 2025; 14(17)DOI:10.1002/cam4.71173. PMID:40926355. IF:3.100(Q2/5D).
09/09/2025
Socioeconomic status and equity among patients with cardiogenic shock
Marcos-Mangas, M, López-Sobrino, T, Ariza-Sole, A, Rueda-Sobella, F, Sanz-Girgas, E, Aboal, J, Pastor, P, Buera, I, Sionis, A, Andrea, R, Rodriguez-López, J, Tomas, C, Bañeras, J, Llaó, I, Sánchez-Salado, JC, Garcia-Garcia, C. Socioeconomic status and equity among patients with cardiogenic shock. Frontiers in Cardiovascular Medicine. 2025; 12DOI:10.3389/fcvm.2025.1597225. PMID:40994919. IF:2.900(Q2/4D).
03/09/2025
Morbidity and Mortality Profile of Leishmaniasis in an Andean Region of Ecuador in the Context of Climate Change
Páez-Espinosa, EV, Sosa-Guzmán, DM, Buitrón-Andrade, LR, Dávila-Jumbo, N, Cáceres-Ruiz, MI, Robalino-Flores, VF, Mato-Matute, E. Morbidity and Mortality Profile of Leishmaniasis in an Andean Region of Ecuador in the Context of Climate Change. Tropical Medicine and Infectious Disease. 2025; 10(9)DOI:10.3390/tropicalmed10090254. PMID:41003564. IF:2.600(Q1/1D).
02/09/2025
An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease
Fortea, J, Ferrer-Picón, E. An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease. Expert Review of Neurotherapeutics. 2025; 25(9)DOI:10.1080/14737175.2025.2527211. PMID:40600688. IF:3.400(Q2/3D).